Stock OJU1 ORAMED PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Oramed Pharmaceuticals Inc. Deutsche Boerse AG

Equities

OJU1

US68403P2039

Market Closed - Deutsche Boerse AG
Other stock markets
 07:04:45 10/05/2024 BST 		5-day change 1st Jan Change
2.186 EUR -1.44% Intraday chart for Oramed Pharmaceuticals Inc. +1.11% +4.54%
05-09 Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-19 Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oramed: Q1 Earnings Snapshot
AQ
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction
PU
Oramed Pharmaceuticals : 13D-Nadav Kidron
PU
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction
PU
Oramed Pharmaceuticals : Other Report or Announcement
PU
Oramed Pharmaceuticals : Other Report or Announcement
PU
Oramed Pharmaceuticals : Other Report or Announcement
PU
Oramed Pharmaceuticals : Other Report or Announcement
PU
Oramed Pharmaceuticals : Form 8-K - Director Appointment- Dr. Daniel Aghion, effective as of January 1, 2024.
PU
Oramed: Q3 Earnings Snapshot
AQ
Oramed Pharmaceuticals : Other Report or Announcement
PU
Oramed Pharmaceuticals : Stalking Horse Stock Purchase Term Sheet - Form 8-K
PU
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally
PR
Oramed to Present at the 83rd American Diabetes Association Conference
AQ
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit
PR
Oramed: Q1 Earnings Snapshot
AQ
ORAMED PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Oramed Appoints Ben Shapiro to its Board of Directors
PR
ORAMED PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
AQ
ORAMED PHARMACEUTICALS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORMP Stock
  4. OJU1 Stock
  5. News Oramed Pharmaceuticals Inc.
  6. Press Releases